RAY B — RaySearch Laboratories AB (publ) Share Price
0.000.00%
Last trade - 00:00- SEK8.50bn
- SEK8.55bn
- SEK1.19bn
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 30.74 | ||
| PEG Ratio (f) | 1.5 | ||
| EPS Growth (f) | 25.81% | ||
| Dividend Yield (f) | 1.21% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 9.7 | ||
| Price to Tang. Book | 25.3 | ||
| Price to Free Cashflow | 31.76 | ||
| Price to Sales | 7.13 | ||
| EV to EBITDA | 15.33 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 18.78% | ||
| Return on Equity | 25.25% | ||
| Operating Margin | 21.85% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | SEKm | 651.61 | 641.67 | 843.65 | 1,022.16 | 1,192.03 | 1,360 | 1,552 | 9.96% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | +243.06 | +149.64 | +25 | +27.21 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
RaySearch Laboratories AB (publ) is a Sweden-based medical technology company that develops software for radiation therapy of cancer. It markets and sells its products mainly in the United States and in Europe through license agreements with medical technology companies and scientific institutions. Additionally, its solutions include software for optimizing Intensity Modulated Radiation Therapy (IMRT) plans for photons, adaptive technology for IMRT treatments and software for proton treatments. The Company’s commercial partners are Philips, Nucletron and IBA Dosimetry, among others. In April 2014, it established a German subsidiary, RaySearch Germany GmbH.
Directors
- Lars Wollung NEC (60)
- Johan Lof CEO (52)
- Bjorn Hardemark DCE (44)
- Peter Thysell CFO (51)
- Kjell Eriksson CSO (48)
- Petra Jansson GCN (47)
- Peter Kemlin DSL (47)
- Niclas Borglund OTH (50)
- Henrik Friberger OTH (49)
- David Hedfors OTH (45)
- Lars Jordeby OTH (55)
- Fredrik Lofman OTH (43)
- Carl Bergendal IND (76)
- Johanna Oberg IND (46)
- Britta Wallgren IND (58)
- Hans Wigzell IND (83)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- April 18th, 1988
- Public Since
- May 29th, 1990
- No. of Employees
- 416
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- OMX Nordic Exchange Stockholm
- Shares in Issue
- 34,282,773
- Address
- Eugeniavagen 18C, STOCKHOLM, 104 30
- Web
- https://www.raysearchlabs.com/
- Phone
- +46 851053000
- Auditors
- Deloitte AB
Upcoming Events for RAY B
Q1 2025 RaySearch Laboratories AB (publ) Earnings Call
RaySearch Laboratories AB (publ) Annual Shareholders Meeting
Dividend For RAYb.ST - 3.0000 SEK
Q2 2025 RaySearch Laboratories AB (publ) Earnings Release
Similar to RAY B
Acarix AB
OMX Nordic Exchange Stockholm
AddLife AB
OMX Nordic Exchange Stockholm
ADDvise AB (publ)
OMX Nordic Exchange Stockholm
ADDvise AB (publ)
OMX Nordic Exchange Stockholm
Arcoma AB
OMX Nordic Exchange Stockholm
FAQ
What is the RaySearch Laboratories AB (publ) share price?
As of Today at 22:52 UTC, shares in RaySearch Laboratories AB (publ) are trading at SEK248.00. This share price information is delayed by 15 minutes.
How has the RaySearch Laboratories AB (publ) share price performed this year?
Shares in RaySearch Laboratories AB (publ) last closed at SEK248.00 and the price had moved by +117.16% over the past 365 days. In terms of relative price strength the RaySearch Laboratories AB (publ) share price has outperformed the FTSE Global All Cap Index by +111.73% over the past year.
What are the analyst and broker recommendations for RaySearch Laboratories AB (publ)?
The overall consensus recommendation for RaySearch Laboratories AB (publ) is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the RaySearch Laboratories AB (publ) dividend yield?
The RaySearch Laboratories AB (publ) dividend yield is 1.21% based on the trailing twelve month period.
Does RaySearch Laboratories AB (publ) pay a dividend?
Last year, RaySearch Laboratories AB (publ) paid a total dividend of SEK3.00, and it currently has a trailing dividend yield of 1.21%.Looking ahead, shares in RaySearch Laboratories AB (publ) are due to go ex-dividend on 2025-05-23 and the next dividend pay date is 2025-05-30.
When does RaySearch Laboratories AB (publ) next pay dividends?
RaySearch Laboratories AB (publ) are due to go ex-dividend on 2025-05-23 and the next dividend pay date is 2025-05-30. The historic dividend yield on RaySearch Laboratories AB (publ) shares is currently 1.21%.
How do I buy RaySearch Laboratories AB (publ) shares?
To buy shares in RaySearch Laboratories AB (publ) you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of RaySearch Laboratories AB (publ)?
As of the previous close price of SEK248.00, shares in RaySearch Laboratories AB (publ) had a market capitalisation of SEK8.50bn.
Where are RaySearch Laboratories AB (publ) shares listed?
Here are the trading details for RaySearch Laboratories AB (publ):
- Country of listing: Sweden
- Exchange: STO
- Ticker Symbol: RAY B
What kind of share is RaySearch Laboratories AB (publ)?
Based on an overall assessment of its quality, value and momentum RaySearch Laboratories AB (publ) is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a RaySearch Laboratories AB (publ) share price forecast for 2025?
The analyst consensus target price for shares in RaySearch Laboratories AB (publ) is SEK350.00. That is 41.13% above the last closing price of SEK248.00.
Analysts covering RaySearch Laboratories AB (publ) currently have a consensus Earnings Per Share (EPS) forecast of SEK7.43 for the next financial year.
Find out moreWhat is the trend in the RaySearch Laboratories AB (publ) share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like RaySearch Laboratories AB (publ). Over the past six months, its share price has outperformed the FTSE Global All Cap Index by +56.96%.
As of the last closing price of SEK248.00, shares in RaySearch Laboratories AB (publ) were trading +27.53% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the RaySearch Laboratories AB (publ) PE Ratio?
The RaySearch Laboratories AB (publ) PE ratio based on its reported earnings over the past 12 months is 30.74. The shares last closed at SEK248.00.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of RaySearch Laboratories AB (publ)?
RaySearch Laboratories AB (publ)'s management team is headed by:
- Lars Wollung - NEC
- Johan Lof - CEO
- Bjorn Hardemark - DCE
- Peter Thysell - CFO
- Kjell Eriksson - CSO
- Petra Jansson - GCN
- Peter Kemlin - DSL
- Niclas Borglund - OTH
- Henrik Friberger - OTH
- David Hedfors - OTH
- Lars Jordeby - OTH
- Fredrik Lofman - OTH
- Carl Bergendal - IND
- Johanna Oberg - IND
- Britta Wallgren - IND
- Hans Wigzell - IND